Mind the Byte makes in-silico drug discovery easily accessible, scalable, and affordable to accelerate the development of new drugs through our unique platform and consultancy services. We work with over 30 biotechnology, pharmaceutical and veterinary companies as well as research centres and universities around the world.
With our SaaS platform, which we expand regularly, we offer a versatile set of programs and applications supporting an efficient drug discovery and development process. Our technology uses Big Data and Machine Learning approaches and the applications are directly developed for our SaaS Platform.
Our ultimate mission is to speed up and facilitate the drug discovery process of meeting patient needs. The platform requires no investment in hardware or software licenses and allows increase or decrease of commitment depending on your actual needs. Hence, the platform allows all organizations a facile entry into computational drug discovery and we retain no IP rights
Mind the Byte was founded in 2011 by Alfons Nonell-Canals, who holds a PhD in Computational Chemistry and is a specialist in computer-aided drug design, in the development of software to modify active compounds, and in large-scale chemical and biological analyses.